FHTX Foghorn Therapeutics Inc.
$4.42▼ -1.56%
Healthcare
Other
After hours
$4.42▲ +0.00%
Sep 11, 7:37 PM ET
Volume 289.1K
Avg Volume (10D) 379.8K
Key Metrics & Fundamentals
Market Cap
$262.48M
P/E Ratio
–
Div Yield
–%
52W Range
3.27 - 7.61
% vs 50 MA
-21.38%
% vs 200 MA
-13.40%
RSI-14
28.0
MACD Histogram
-0.2500
Beta (1Y vs SPY)
1.85
Free Cash Flow
-$17.89M
Gross Rev
$16.07M
Gross Profit
$16.07M
EBITDA
-$8.58M
COGS
–
Operating Exp
$24.88M
Operating Income
-$8.81M
EBIT
-$8.81M
Pretax Income
-$7.19M
Net Income
-$7.19M
EPS (Diluted)
-0.10
Price & Volume History
Loading chart…
Recent News
Wall Street Analysts Think Foghorn Therapeutics (FHTX) Could Surge 67.01%: Read This Before Placing a Bet
Zacks · Aug 26, 2026 1:55 PM
Here's Why Foghorn Therapeutics Inc. (FHTX) is a Great Momentum Stock to Buy
Zacks · Aug 14, 2026 4:00 PM
Wall Street Analysts Believe Foghorn Therapeutics (FHTX) Could Rally 88.47%: Here's is How to Trade
Zacks · Aug 10, 2026 1:55 PM
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 6, 2026 1:50 PM
Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update
GlobeNewswire · Aug 6, 2026 11:00 AM
Acadia Healthcare (ACHC) Surpasses Q2 Earnings and Revenue Estimates
Zacks · Jul 28, 2026 10:00 PM
Foghorn Therapeutics (FHTX) Surges 5.8%: Is This an Indication of Further Gains?
Zacks · Jul 3, 2026 11:42 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See FHTX's money flow as a full page
Social Sentiment
No Reddit posts found for FHTX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.